Your browser doesn't support javascript.
loading
High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire.
Kucharska, Iga; Binter, Spela; Murugan, Rajagopal; Scally, Stephen W; Ludwig, Julia; Prieto, Katherine; Thai, Elaine; Costa, Giulia; Li, Kan; Horn, Gillian Q; Flores-Garcia, Yevel; Bosch, Alexandre; Sicard, Taylor; Rubinstein, John L; Zavala, Fidel; Dennison, S Moses; Tomaras, Georgia D; Levashina, Elena A; Kellam, Paul; Wardemann, Hedda; Julien, Jean-Philippe.
Afiliación
  • Kucharska I; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.
  • Binter S; Kymab Ltd., The Bennet Building (B930) Babraham Research Campus, Cambridge, United Kingdom.
  • Murugan R; B Cell Immunology, German Cancer Research Institute (DKFZ), Heidelberg, Germany.
  • Scally SW; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.
  • Ludwig J; B Cell Immunology, German Cancer Research Institute (DKFZ), Heidelberg, Germany.
  • Prieto K; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.
  • Thai E; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.
  • Costa G; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
  • Li K; Vector Biology Unit, Max Planck Institute for Infection Biology, Berlin, Germany.
  • Horn GQ; Department of Surgery, Immunology, Molecular Genetics and Microbiology, Center for Human Systems Immunology, Duke University, Durham, North Carolina, United States of America.
  • Flores-Garcia Y; Department of Surgery, Immunology, Molecular Genetics and Microbiology, Center for Human Systems Immunology, Duke University, Durham, North Carolina, United States of America.
  • Bosch A; Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
  • Sicard T; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.
  • Rubinstein JL; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.
  • Zavala F; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
  • Dennison SM; Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Canada.
  • Tomaras GD; Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
  • Levashina EA; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Kellam P; Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
  • Wardemann H; Department of Surgery, Immunology, Molecular Genetics and Microbiology, Center for Human Systems Immunology, Duke University, Durham, North Carolina, United States of America.
  • Julien JP; Department of Surgery, Immunology, Molecular Genetics and Microbiology, Center for Human Systems Immunology, Duke University, Durham, North Carolina, United States of America.
PLoS Pathog ; 18(11): e1010999, 2022 11.
Article en En | MEDLINE | ID: mdl-36441829

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Malaria Falciparum / Vacunas contra la Malaria / Malaria Idioma: En Revista: PLoS Pathog Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Malaria Falciparum / Vacunas contra la Malaria / Malaria Idioma: En Revista: PLoS Pathog Año: 2022 Tipo del documento: Article